219 related articles for article (PubMed ID: 28073184)
21. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.
Yuan J; Ji H; Xiao F; Lin Z; Zhao X; Wang Z; Zhao J; Lu J
Biochem Biophys Res Commun; 2017 Jan; 483(1):578-584. PubMed ID: 27998770
[TBL] [Abstract][Full Text] [Related]
22. Stanniocalcin-1 Reduces Tumor Size in Human Hepatocellular Carcinoma.
Yeung BH; Shek FH; Lee NP; Wong CK
PLoS One; 2015; 10(10):e0139977. PubMed ID: 26469082
[TBL] [Abstract][Full Text] [Related]
23. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
[TBL] [Abstract][Full Text] [Related]
24. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
26. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
27. [Effect of bear bile powder on STAT3 pathway in hepatocellular carcinoma xenograft].
Zhao JY; Liu LY; Shen AL; Lin W; Cao ZY; Zhuang QC; Hong ZF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):976-81. PubMed ID: 25223184
[TBL] [Abstract][Full Text] [Related]
28. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Zhi XT; Zhou JW; Li DK; Chen ZT; Chen ZQ; Hu SY
Liver Int; 2015 Apr; 35(4):1416-29. PubMed ID: 25066210
[TBL] [Abstract][Full Text] [Related]
29. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
[TBL] [Abstract][Full Text] [Related]
30. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
[TBL] [Abstract][Full Text] [Related]
31. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.
Li H; Miao Q; Xu CW; Huang JH; Zhou YF; Wu MJ
J Korean Med Sci; 2016 Aug; 31(8):1215-23. PubMed ID: 27478331
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
33. Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma.
Woo CC; Chen WC; Teo XQ; Radda GK; Lee PT
Oncotarget; 2016 Aug; 7(33):53005-53017. PubMed ID: 27391339
[TBL] [Abstract][Full Text] [Related]
34. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
[TBL] [Abstract][Full Text] [Related]
35. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling.
Yang G; Liang Y; Zheng T; Song R; Wang J; Shi H; Sun B; Xie C; Li Y; Han J; Pan S; Lan Y; Liu X; Zhu M; Wang Y; Liu L
Cancer Lett; 2016 Aug; 378(2):80-6. PubMed ID: 27177473
[TBL] [Abstract][Full Text] [Related]
36. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
[TBL] [Abstract][Full Text] [Related]
37. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
39. Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis.
Gu L; Zhu Y; Lin X; Tan X; Lu B; Li Y
Oncogene; 2020 Mar; 39(11):2437-2449. PubMed ID: 31974474
[TBL] [Abstract][Full Text] [Related]
40. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma.
Abel S; De Kock M; van Schalkwyk DJ; Swanevelder S; Kew MC; Gelderblom WC
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):391-9. PubMed ID: 19782547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
